2022
DOI: 10.1016/j.hrthm.2022.03.008
|View full text |Cite
|
Sign up to set email alerts
|

Adverse events associated with the AtriClip device for left atrial appendage occlusion: A Food and Drug Administration MAUDE database study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 4 publications
0
4
0
Order By: Relevance
“…In one review, in 113 of reported adverse events connected with the use of AtriClip (AtriCure, Inc., Mason, OH, USA), 4 (3.5%) were classified as coronary artery damage, making them the most common in the group of collateral injuries during AtriClip use. 14 In addition, for the Watchman device (Boston Scientific, Marlborough, MA, USA), we found 2 cases of Cx damage and 3 cases of LAA/Cx fistula formation due to device implantation in the US Food and Drug Administration MAUDE database from 2018 to date. There were no reports in this database of Cx damage due to the LARIAT device (SentreHEART, Inc., Pleasanton, CA, USA).…”
Section: Discussionmentioning
confidence: 86%
“…In one review, in 113 of reported adverse events connected with the use of AtriClip (AtriCure, Inc., Mason, OH, USA), 4 (3.5%) were classified as coronary artery damage, making them the most common in the group of collateral injuries during AtriClip use. 14 In addition, for the Watchman device (Boston Scientific, Marlborough, MA, USA), we found 2 cases of Cx damage and 3 cases of LAA/Cx fistula formation due to device implantation in the US Food and Drug Administration MAUDE database from 2018 to date. There were no reports in this database of Cx damage due to the LARIAT device (SentreHEART, Inc., Pleasanton, CA, USA).…”
Section: Discussionmentioning
confidence: 86%
“…The AtriClip comprising two parallel titanium tubes with elastic nitinol springs covered with knit-braided polyester ( Figure 4 ) is an option for LAA closure, and coronary occlusion is a potentially fatal complication of this procedure. Contractor et al 3 reported adverse events associated with the AtriClip. During the timeframe of the study, ∼274 000 AtriClips were sold and nearly 41 000 were being deployed thoracoscopically.…”
Section: Discussionmentioning
confidence: 99%
“…Upon manual review, 135 articles with unclear queries 32–164 and 120 with incomplete queries 165–284 were excluded. Ultimately, 60 executable queries were found 5,10,285–342 . A comprehensive flowchart of this selection process is depicted in Figure 1.…”
Section: Methodsmentioning
confidence: 99%